GlassScriptPhysician profile
Lucas Chan
NPI 1578094710
$36,487.25
in general payments reported to CMS, 2019-2025
29 companies · $13K in 2025
The $13K reported for 2025 was more than what 84% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $18K · 2022: $373 · 2023: $1,534 · 2024: $3,098 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $8,750 · Food and Beverage: $4,730 · Travel and Lodging: $3,755 · Education: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $8,750.00 |
| Food and Beverage | $4,729.83 |
| Travel and Lodging | $3,754.77 |
| Education | $879.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $29,591.04 | 2021-2025 | Gallant, Assurity, Tacticath |
| Medtronic, INC. | $2,770.51 | 2023-2025 | Symplicity G3, Onyx Frontier, Azure Xt Dr Mri Surescan |
| Biosense Webster, INC. | $1,583.59 | 2024-2025 | Carto 3 |
| Sanofi-Aventis U.S. LLC | $280.51 | 2022-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $248.56 | 2022-2024 | Lifevest |
| Amgen INC. | $238.64 | 2022-2023 | Repatha |
| Abiomed | $204.38 | 2024-2025 | Impella |
| Inari Medical, INC. | $182.57 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Atricure, INC. | $178.42 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Actelion Pharmaceuticals US, INC. | $161.85 | 2024 | Uptravi, Opsumit |
| Novartis Pharmaceuticals Corporation | $160.66 | 2023-2025 | |
| Biotronik INC. | $136.70 | 2025 | |
| Irhythm Technologies, INC. | $123.54 | 2024 | Zio Monitor, Zio Xt Patch |
| Esperion Therapeutics, INC. | $118.24 | 2024 | Nexletol |
| Penumbra, INC. | $100.00 | 2023 | Red 72 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $79.71 | 2022-2025 | Watchman Access System |
| Cardiva Medical, INC. | $46.91 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $43.02 | 2024 | |
| Terumo Medical Corporation | $29.16 | 2023 | Glidesheath Slender, Angio-Seal, Tr Band |
| Alnylam Pharmaceuticals INC. | $29.06 | 2024 | Onpattro |
| Getinge USA Sales, LLC | $26.53 | 2023 | Cardiosave Hybrid, Type B Plug |
| Edwards Lifesciences Corporation | $22.68 | 2023 | Sapien 3 Ultra Resilia |
| Shockwave Medical, INC | $21.58 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $20.60 | 2024 | Andexxa |
| Lexicon Pharmaceuticals, INC. | $19.90 | 2024 | |
| Cordis US Corp. | $19.64 | 2025 | Mynx Control Venous |
| Heartflow, INC. | $18.23 | 2024 | |
| Bridgebio Pharma, INC. | $17.95 | 2025 | Attruby |
| W. L. Gore & Associates, INC. | $13.07 | 2023 | Gore Viabahn Vbx Balloon Expandable Endo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucas Chan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.